1st Gen. CA Approval: 2010. 12.13
1st Gen. EU Approval: 2010. 12.13
1st Gen. USA Approval: 2010. 12.13
2nd Gen. USA Approval: 2017. 06.20
>Clearance Technology
Company
Company Web-Site
Patent>Assignee; No. Etc. (1st Gen)
Patent>Total USA No.: 8
Patent>UpDate: 2017. 06.20
RBS: Retained Blood Syndrome
TradeMark (1st Gen.)
TradeMark (2nd Gen.)